BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28484907)

  • 21. Hepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases.
    Havlasek J; Vrba J; Zatloukalova M; Papouskova B; Modriansky M; Storch J; Vacek J
    Toxicol Appl Pharmacol; 2023 Oct; 476():116654. PubMed ID: 37574147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.
    Sridar C; Goosen TC; Kent UM; Williams JA; Hollenberg PF
    Drug Metab Dispos; 2004 Jun; 32(6):587-94. PubMed ID: 15155549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
    Cao L; Greenblatt DJ; Kwara A
    Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Illingworth NA; Boddy AV; Daly AK; Veal GJ
    Br J Pharmacol; 2011 Feb; 162(4):989-99. PubMed ID: 21054342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effects of
    Seo HJ; Ji SB; Kim SE; Lee GM; Park SY; Wu Z; Jang DS; Liu KH
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802239
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
    Kim SB; Kim KS; Kim DD; Yoon IS
    Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
    Liu Y; She M; Wu Z; Dai R
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
    Knights KM; Rowland A; Miners JO
    Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
    Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
    Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Metabolism of Montelukast by Cytochrome P450s and UDP-Glucuronosyltransferases.
    Cardoso Jde O; Oliveira RV; Lu JB; Desta Z
    Drug Metab Dispos; 2015 Dec; 43(12):1905-16. PubMed ID: 26374173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
    Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
    Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
    Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
    Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
    Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite.
    Liu S; Hou L; Li C; Zhao Y; Yao X; Zhang X; Tian X
    Front Pharmacol; 2021; 12():761814. PubMed ID: 34721047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes.
    Jin SE; Ha H; Shin HK
    J Med Food; 2018 Nov; 21(11):1173-1187. PubMed ID: 30457473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.